Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines - Scorecard - MDSpire
Advertisement
Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines
Clinical Scorecard: Alterations in Trabecular and Cortical Bone Microarchitecture Linked to Chronic Hepatitis C Infection and Specific Inflammatory Cytokines
At a Glance
Category
Detail
Condition
Chronic Hepatitis C Virus (HCV) Infection
Key Mechanisms
HCV-associated inflammation elevates tumor necrosis factor α (TNF-α), leading to decreased osteoblast activity, increased osteoblast apoptosis, and stimulated osteoclast activation causing reduced bone mineral density (BMD) and altered bone microarchitecture
Target Population
Adults with chronic HCV infection
Care Setting
Viral hepatitis and primary care clinical settings
Key Highlights
Chronic HCV infection is associated with lower trabecular volumetric BMD and reduced cortical area and thickness in radius and tibia independent of age, sex, body composition, and smoking.
Patients with chronic HCV have higher serum TNF-α levels, which correlate with lower trabecular and cortical volumetric BMD and increased cortical porosity.
HR-pQCT imaging reveals specific deficits in bone microarchitecture in chronic HCV beyond what is detected by standard DXA.
Guideline-Based Recommendations
Diagnosis
Use high-resolution peripheral quantitative computed tomography (HR-pQCT) to assess trabecular and cortical bone compartments in patients with chronic HCV for detailed bone microarchitecture evaluation.
Measure serum inflammatory cytokines, especially TNF-α, to evaluate inflammatory contributions to bone deficits.
Management
Address chronic inflammation in HCV patients as a potential contributor to bone loss.
Consider bone health monitoring and fracture risk assessment in patients with chronic HCV infection.
Monitoring & Follow-up
Regularly monitor bone mineral density and bone microarchitecture in chronic HCV patients, especially those with elevated TNF-α levels.
Assess traditional osteoporosis risk factors such as smoking and alcohol use in this population.
Risks
Increased fracture risk in chronic HCV patients due to combined effects of low BMD and altered bone microarchitecture.
Potential exacerbation of bone loss by elevated inflammatory cytokines, particularly TNF-α.
Patient & Prescribing Data
Adults with chronic hepatitis C infection
Inflammation-mediated bone deficits suggest that therapies targeting TNF-α or inflammation may benefit bone health; however, further studies are needed to inform specific treatment strategies.
Clinical Best Practices
Incorporate assessment of bone microarchitecture using HR-pQCT in addition to DXA for comprehensive bone health evaluation in chronic HCV patients.
Evaluate and manage modifiable osteoporosis risk factors such as smoking and alcohol consumption in this population.
Monitor inflammatory cytokine levels, particularly TNF-α, as biomarkers for bone health deterioration.
Recognize that bone fragility in chronic HCV is multifactorial, involving both reduced BMD and microarchitectural changes.
by Erica J Weinstein, Dean M Carbonari, Craig W Newcomb, Jessie Torgersen, Shanae M Smith, Katherine L Brecker, X Sherry Liu, Jay R Kostman, Stacey Trooskin, Rebecca A Hubbard, Joshua F Baker, Babette S Zemel, Mary B Leonard, Vincent Lo Re
